29 September 2016 - Deborah Wilkes
Archived
GlaxoSmithKline has promoted Brian McNamara to chief executive officer of its Consumer Healthcare division with immediate effect. He replaces Emma Walmsley who was recently appointed GlaxoSmithKline's chief executive officer designate to succeed Andrew Witty in 2017.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.